More articles from SELECTED ABSTRACTS - HMORN 2011: Pharmacoepidemiology

• PS1-40: Laboratory Monitoring of HEDIS Medications in the Ambulatory Setting: The Relative Contribution of Physician and Patient Behavior to Undermonitoring

  Jennifer Tjia, Terry Field, Marsha Raebel, Shira Fischer, Dan Peterson, Yanfang Zhao, Shawn Gagne and Jerry Gurwitz

  • Clinical Medicine & Research November 2011, 9 (3-4) 178-179;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-40
• C-C5-04: Can Claims Data Accurately Identify Graft Type and Infections Following Anterior Cruciate Ligament Repairs?

  Michael Klompas, Michael Murphy, Aysha Akhtar, Cynthia Nakasato, James Nordin, Michael Schum, Ann von Worley, Melissa Butler, Robert Davis, Laura Johnson, Mayur Ramesh, Craig Zinderman, Hector Izurieta and Richard Platt

  • Clinical Medicine & Research November 2011, 9 (3-4) 179;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-c5-04
• C-A4-05: Design for Identification, Retrieval and Adjudication of Acute Myocardial Infarction Cases in the Mini-Sentinel Distributed Database

  Sarah Cutrona, Sarah Foy, Darren Toh, Aarthi Iyer, Susan Forrow and Jerry Gurwitz

  • Clinical Medicine & Research November 2011, 9 (3-4) 179;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-a4-05
• PS1-29: Preparing for Genetics Research on Serious Skin Rash in the HMO Research Network

  Cynthia Nakasato, Mark Schmidt, Aileen Uchida, Tracy Thomas, Mia Hemmes and Robert Davis

  • Clinical Medicine & Research November 2011, 9 (3-4) 179-180;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-29
• C-C5-01: Drug Safety Data Mining with a Tree-Based Scan Statistic

  Jeffrey Brown, Inna Dashevsky, Bruce Fireman, Lisa Herrinton, David McClure, Michael Murphy, Marsha Raebel, Jessica Sturtevant and Martin Kulldorff

  • Clinical Medicine & Research November 2011, 9 (3-4) 180;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-c5-01
• PS1-31: Assessing the Potential for Research on Genetics of Drug Induced Liver Injury in the HMORN

  Pamala Pawloski, Brita Hedblom, Paul Hitz, Brian Owens, Chris Anderson, Catherine McCarty, Steven Yale, Robert Davis, Mia Hemmes and John Schmelzer

  • Clinical Medicine & Research November 2011, 9 (3-4) 180;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-31
• PS1-18: A Feasibility Pilot to Determine the Practicality of Using the HMO Research Network to Research the Genetics of Drug-Induced Serious Adverse Events

  Mia Hemmes, David Arterburn, Glen Gerhard, Catherine McCarty, Cynthia Nakasato, Pamala Pawloski, Margaret Rukstalis, John Schmelzer, Steven Yale and Robert Davis

  • Clinical Medicine & Research November 2011, 9 (3-4) 180-181;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-18
• PS1-23: The Incidence and Epidemiology of Inpatient and Outpatient Clostridium difficile Infections at Kaiser Permanente

  Jennifer Kuntz, Eric Johnson, Marsha Raebel, Amanda Petrik, Xiuhai Yang, Karen Glenn, Micah Thorp, Nancy Neil and David Smith

  • Clinical Medicine & Research November 2011, 9 (3-4) 181;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-23
• PS1-11: Feasibility of Prospective Surveillance for Adverse Drug Events – Lessons Learned from a 12-Month Pilot Study

  Sascha Dublin, Taliser Avery, Craig Cheetham, Robert Davis, Martin Kulldorff, Lingling Li, Liyan Liu and Jeffrey Brown

  • Clinical Medicine & Research November 2011, 9 (3-4) 181;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-11
• C-C5-05: Genetic Risk Factors: Idiopathic Thrombocytopenic Purpura following the First Dose of Measles-Mumps-Rubella Vaccination in Children

  Mia Hemmes, Robert Davis, Thomas Buttolph, Yandong Qiang, Deborah Nickerson, Jill Johnsen and Christopher Carlson

  • Clinical Medicine & Research November 2011, 9 (3-4) 181-182;
  • DOI: https://doi.org/10.3121/cmr.2011.1020.c-c5-05